4//SEC Filing
KANEKO YASUNORI 4
Accession 0001209191-20-034985
CIK 0001724521other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 4:31 PM ET
Size
13.4 KB
Accession
0001209191-20-034985
Insider Transaction Report
Form 4
KANEKO YASUNORI
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-04+14,000→ 14,000 totalExercise: $30.05Exp: 2030-06-03→ Common Stock (14,000 underlying) - Award
Common Stock
2020-06-04+3,000→ 3,000 total - Exercise/Conversion
Common Stock
2020-06-05$7.99/sh+35,000$279,650→ 38,000 total - Exercise/Conversion
Stock Option (Rights to Buy)
2020-06-05−35,000→ 0 totalExercise: $7.99From: 2020-06-04Exp: 2029-06-05→ Common Stock (35,000 underlying)
Holdings
- 252,524(indirect: By LLC)
Common Stock
- 96,948(indirect: By Trust)
Common Stock
- 505,050(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]Represents the grant of restricted stock units that vest 100% on the earlier of June 4, 2021 or the next annual meeting of the stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control
- [F2]Represents the exercise of options to purchase common stock by the reporting person. No shares were sold by the reporting person, and the shares received upon the exercise of such options are subject to a lock-up agreement with the underwriters for the Company's recent public offering.
- [F3]The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001277503
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 4:31 PM ET
- Size
- 13.4 KB